Cboe Digital to become first U.S. regulated crypto native exchange and clearinghouse to enable both spot and leveraged derivatives trading on a single platform11 leading firms across crypto and traditional finance
Companies Reporting Before The Bell
• Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.
Benzinga’s Michael Murray sat down with Jonathan Zaionz, Senior Derivatives Analyst at Cboe Global Markets (BATS: CBOE), to discuss 0DTE - zero days to expiration - options.
Explore how CBOE Global Markets is thriving amidst global turmoil, with record-breaking volumes, potential earnings surprises, and CEO exit speculation.